Cerity Partners’s VanEck Biotech ETF BBH Stock Holding History

Cerity Partners’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	5,543 -10	-0.2%	-$1.88K	﹤0.01%	1934
2026 Q1	$1.04M	Sell	5,553 -242	-4%	-$46.6K	﹤0.01%	1840
2025 Q4	$1.1M	Hold	5,795	–	–	﹤0.01%	1670
2025 Q3	$960K	Hold	5,795	–	–	﹤0.01%	1615
2025 Q2	$888K	Buy	5,795 +43	+0.7%	+$6.4K	﹤0.01%	1574
2025 Q1	$905K	Sell	5,752 -358	-6%	-$58.1K	﹤0.01%	1473
2024 Q4	$959K	Hold	6,110	–	–	﹤0.01%	1433
2024 Q3	$1.08M	Hold	6,110	–	–	﹤0.01%	1356
2024 Q2	$1.03M	Sell	6,110 -278	-4%	-$45.5K	﹤0.01%	1214
2024 Q1	$997K	Buy	6,388 +636	+11%	+$105K	﹤0.01%	1281
2023 Q4	$951K	Buy	5,752 +52	+0.9%	+$8K	﹤0.01%	1002
2023 Q3	$888K	Sell	5,700 -51	-0.9%	-$8.15K	﹤0.01%	789
2023 Q2	$898K	Hold	5,751	–	–	﹤0.01%	956
2023 Q1	$932K	Buy	+5,751	New	+$930K	﹤0.01%	1010

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Cerity Partners's BBH Position: Q2 2026 in Review

Cerity Partners reduced its VanEck Biotech ETF (BBH) stake by 0.18% in Q2 2026, selling an estimated $1.88K and leaving 5,543 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Cerity Partners first reported a position in BBH in Q1 2023 and has held it in 14 quarters since. 104 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Cerity Partners held 5,543 shares of VanEck Biotech ETF worth $1.13M as of Q2 2026.
Cerity Partners sold 10 VanEck Biotech ETF shares in Q2 2026, an estimated $1.88K.
VanEck Biotech ETF made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1934 holding.
Cerity Partners first reported a position in VanEck Biotech ETF in Q1 2023 and has held it in 14 quarters since.
104 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.